Translate
Brain Tumour Complex
Complex Brain Tumour Surgery is an advanced neurosurgical procedure performed for deep-seated, eloquent-region, or high-grade intracranial tumours — using intraoperative MRI, awake craniotomy, fluorescence-guided resection, and neurophysiological monitoring to achieve the maximum safe resection while protecting all vital neurological functions.
Overview
Complex Brain Tumour Surgery is required when intracranial tumours are located near eloquent brain structures — including motor and speech cortex, visual pathways, and deep white matter tracts — or when the tumour size, vascularity, or infiltrative nature makes resection technically demanding. Advanced intraoperative technologies including 5-ALA fluorescence-guided resection, intraoperative MRI, continuous neurophysiological monitoring, and awake craniotomy with cortical mapping are employed to maximise the extent of resection while preserving neurological function. The goal is always the safest maximal resection — balancing the oncological benefit of tumour removal against the imperative of protecting the patient's quality of life.
Types of Complex Brain Tumour Surgery
Complex brain tumour surgery encompasses a variety of sophisticated approaches tailored to the tumour type, location, and the proximity to critical neural structures.
- Awake Craniotomy with Cortical Mapping (for tumours in speech and motor cortex)
- Fluorescence-Guided Resection with 5-ALA (for high-grade glioma — tumour lights up pink)
- Intraoperative MRI-Guided Resection (real-time imaging confirms extent of resection)
- Skull Base Surgery for Complex Deep Tumours (advanced approaches to sellar, parasellar, and clival tumours)
- Endoscopic Endonasal Skull Base Resection (minimally invasive transsphenoidal approach for pituitary and skull base tumours)
Risk Factors for Complex Brain Tumours
Complex intracranial tumours arise from a combination of genetic, environmental, and acquired factors. Understanding these helps the neuro-oncology team plan the most comprehensive treatment.
- IDH mutation and 1p/19q co-deletion status determining tumour biology and treatment response
- MGMT promoter methylation predicting chemotherapy sensitivity in glioblastoma
- Prior therapeutic brain irradiation increasing risk of radiation-induced neoplasms
- NF1 and NF2 hereditary syndromes associated with specific complex brain tumour types
- Immunosuppression from HIV, transplant, or haematological malignancy for CNS lymphoma
- EGFR amplification and PTEN loss — molecular markers influencing aggressive glioma biology
Complex Brain Tumour Symptoms
Complex brain tumours produce symptoms reflecting both the direct neurological impact of the tumour and the raised intracranial pressure from its mass effect. These symptoms require immediate specialist neuro-oncological assessment.
- Progressive motor weakness or speech difficulty worsening over weeks to months
- New-onset or worsening epileptic seizures refractory to antiepileptic medication
- Cognitive decline, memory impairment, and personality or behavioural changes
- Severe morning headache with nausea and vomiting from raised ICP
- Progressive visual field defect or diplopia from tumour compressing visual pathways
- Ataxia, balance difficulty, and coordination problems from cerebellar or brainstem involvement
- Rapid neurological deterioration from haemorrhage within the tumour mass
- Hydrocephalus causing further raised ICP from CSF pathway obstruction by the tumour
Key Benefits
Discover the advantages of choosing our brain tumour complex services.
Maximum safe resection achieved using the most advanced intraoperative technologies available
5-ALA fluorescence guidance allows identification of tumour margins invisible to white light
Awake surgery preserves speech and motor function in eloquent region tumours
Comprehensive histological and molecular profiling guides the most effective adjuvant treatment
Multi-disciplinary team approach optimises every aspect of surgical and oncological management
Clinical Features
The technology, techniques and clinical approach behind our brain tumour complex.
5-ALA fluorescence distinguishes malignant tumour from normal brain tissue under violet light
Awake craniotomy available for tumours adjacent to speech, motor, or cognitive cortex
Continuous neurophysiological monitoring throughout resection protects eloquent neural pathways
Intraoperative MRI available to confirm extent of resection before wound closure in selected cases
Neuro-oncology multi-disciplinary team meeting coordinates all adjuvant treatment planning
Preparation Instructions
After Complex Brain Tumour Surgery, take all prescribed dexamethasone and antiepileptic medications without interruption and follow the tapering schedule provided. Attend the histopathology results consultation within 7 to 10 days and the multi-disciplinary neuro-oncology team meeting to discuss adjuvant radiotherapy and chemotherapy planning based on final tumour classification. Serial MRI surveillance is arranged at 3-month intervals initially to monitor for recurrence. Contact your neurosurgical team immediately for sudden neurological deterioration, seizures, severe headache, fever, or wound complications.
The Procedure
Step-by-step guide to what you can expect during your brain tumour complex procedure.
Multi-Disciplinary Neuro-Oncology Planning
Your neurosurgeon, neuro-oncologist, neuroradiologist, and neuropsychologist review all preoperative imaging including fMRI, DTI, and spectroscopy to plan the approach that achieves the maximum safe resection while protecting all critical speech, motor, and cognitive functions.
Advanced Intraoperative Technology Setup
Continuous MEP and SSEP neuromonitoring, 5-ALA fluorescence equipment, intraoperative ultrasound, and neuronavigation are all confirmed functioning before anaesthesia is induced — these tools collectively define the safety and accuracy of complex tumour surgery.
Craniotomy with Neuronavigation Guidance
The bone flap is planned and executed using neuronavigation to provide the most brain-sparing corridor to the tumour. For awake surgery, the patient is woken at this stage and communication testing begins before any tumour resection starts.
5-ALA Fluorescence-Guided Resection
Under the operating microscope with 5-ALA fluorescent light, malignant high-grade tumour tissue glows pink while normal brain remains dark — allowing your neurosurgeon to identify and resect tumour margins that would be indistinguishable under white light alone.
Continuous Neurological Monitoring During Resection
The patient is asked to speak, move, or perform specific tasks throughout awake resection while the neurosurgeon continuously maps the function of brain tissue adjacent to the tumour — stopping resection immediately at any functional boundary.
ICU Care and Neuro-Oncology Coordination
Post-operative ICU monitoring is followed by early engagement of the neuro-oncology and rehabilitation teams. Histopathology including molecular markers guides the adjuvant treatment plan discussed at the multi-disciplinary neuro-oncology team meeting.
What to Expect
Complex Brain Tumour Surgery is performed under general anaesthesia (or awake for eloquent cortex tumours) and takes 3 to 5 hours. Advanced technologies including neuronavigation, intraoperative monitoring, and 5-ALA fluorescence enable the neurosurgeon to systematically remove all identifiable tumour while continuously monitoring and protecting critical neural function. ICU monitoring for 24 to 48 hours is followed by ward-based physiotherapy, speech therapy, and occupational therapy as needed.
Frequently Asked Questions
Common questions about brain tumour complex.
Related Services
Explore other services in our Nephrology department.
Haemodialysis Access Surgery
Renal Biopsy
Peritoneal Dialysis Catheter Insertion
Ready to Get Started?
Schedule your consultation today and take the first step towards better health.
